Stryker Expands Foot & Ankle Portfolio With Specialized Offerings Designed to Enhance Surgical Precision and Outcomes
Stryker (NYSE:SYK) has expanded its Foot & Ankle portfolio with two new products: the Osteotomy Truss System™ (OTS) and Ankle Truss System™ (ATS), acquired from 4WEB Medical. These innovations will be showcased at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Vancouver from Sept. 11-14, 2024.
The ATS, featuring Arthrosphere® and Arthrocube™ implants, is designed for tibiotalocalcaneal fusions, offering structural support and promoting fusion. The OTS provides a comprehensive solution for osteotomy needs. Stryker will also highlight the Artelon Flexband and celebrate the 10th anniversary of the Infinity Total Ankle System, which boasts a 95.9% survivorship rate at seven years.
Stryker (NYSE:SYK) ha ampliato il suo portfolio di prodotti per il piede e la caviglia con due nuove soluzioni: il Sistema di Truss per Osteotomia™ (OTS) e il Sistema di Truss per Caviglia™ (ATS), acquisiti da 4WEB Medical. Queste innovazioni saranno presentate al Meeting Annuale della Società Americana di Ortopedia per Piede e Caviglia (AOFAS) a Vancouver dal 11 al 14 settembre 2024.
L'ATS, dotato di impianti Arthrosphere® e Arthrocube™, è progettato per fusione tibiotalocalcaneale, offrendo supporto strutturale e favorendo la fusione. L'OTS fornisce una soluzione completa per le esigenze di osteotomia. Stryker metterà in evidenza anche l'Artelon Flexband e celebrerà il decimo anniversario del Sistema Total Ankle Infinity, che vanta un tasso di sopravvivenza del 95,9% dopo sette anni.
Stryker (NYSE:SYK) ha ampliado su cartera de productos para el pie y el tobillo con dos nuevos productos: el Sistema de Truss para Osteotomía™ (OTS) y el Sistema de Truss para Tobillo™ (ATS), adquiridos de 4WEB Medical. Estas innovaciones se presentarán en la Reunión Anual de la Sociedad Americana de Ortopedia para Pie y Tobillo (AOFAS) en Vancouver del 11 al 14 de septiembre de 2024.
El ATS, que cuenta con implantes Arthrosphere® y Arthrocube™, está diseñado para fusiones tibiotalocalcaneales, ofreciendo soporte estructural y promoviendo la fusión. El OTS proporciona una solución integral para las necesidades de osteotomía. Stryker también destacará el Artelon Flexband y celebrará el décimo aniversario del Sistema Total de Tobillo Infinity, que cuenta con una tasa de supervivencia del 95.9% a los siete años.
Stryker (NYSE:SYK)는 4WEB Medical로부터 인수한 두 가지 새로운 제품, 골절 트러스 시스템™ (OTS)와 발목 트러스 시스템™ (ATS)으로 발 및 발목 포트폴리오를 확장했습니다. 이러한 혁신은 2024년 9월 11일부터 14일까지 밴쿠버에서 열리는 미국 정형외과 발 및 발목 학회(AOFAS) 연례 회의에서 선보일 예정입니다.
ATS는 Arthrosphere® 및 Arthrocube™ 이식물을 특징으로 하며, 경골-발꿈치-발목 융합을 위해 설계되어 구조적 지원을 제공하고 융합을 촉진합니다. OTS는 골절 요구에 대한 포괄적인 솔루션을 제공합니다. Stryker는 또한 Artelon Flexband를 강조하고 Infinity Total Ankle System의 10주년을 기념할 것입니다. 이 시스템은 7년 동안 95.9%의 생존율을 자랑합니다.
Stryker (NYSE:SYK) a élargi son portefeuille de produits pour le pied et la cheville avec deux nouveaux éléments : le Système de Truss pour Ostéotomie™ (OTS) et le Système de Truss pour Cheville™ (ATS), acquis de 4WEB Medical. Ces innovations seront présentées lors de la Réunion Annuelle de la Société Américaine d'Orthopédie du Pied et de la Cheville (AOFAS) à Vancouver, du 11 au 14 septembre 2024.
Le ATS, comportant des implants Arthrosphere® et Arthrocube™, est conçu pour les fusions tibiotalocalcanéennes, offrant un support structurel et favorisant la fusion. L’OTS fournit une solution complète pour les besoins d'ostéotomie. Stryker mettra également en avant l'Artelon Flexband et célébrera le dixième anniversaire du Système Total de Cheville Infinity, qui possède un taux de survie de 95,9 % après sept ans.
Stryker (NYSE:SYK) hat sein Portfolio für Fuß- und Knöchelprodukte mit zwei neuen Produkten erweitert: dem Osteotomie-Truss-System™ (OTS) und dem Knöchel-Truss-System™ (ATS), die von 4WEB Medical übernommen wurden. Diese Innovationen werden auf dem Jahrestreffen der American Orthopaedic Foot & Ankle Society (AOFAS) in Vancouver vom 11. bis 14. September 2024 vorgestellt.
Das ATS, ausgestattet mit Arthrosphere® und Arthrocube™ Implantaten, ist für tibiotalocalcaneale Fusionen konzipiert, bietet strukturelle Unterstützung und fördert die Fusion. Das OTS bietet eine umfassende Lösung für Osteotomiebedürfnisse. Stryker wird auch das Artelon Flexband hervorheben und das 10-jährige Jubiläum des Infinity Total Ankle Systems feiern, das eine Überlebensrate von 95,9 % nach sieben Jahren aufweist.
- Expansion of Foot & Ankle portfolio with innovative OTS and ATS products
- ATS designed to restore limb length and provide structural integrity for TTC fusions
- OTS offers comprehensive solution for all surgeon's osteotomy needs
- Infinity Total Ankle System demonstrates 95.9% survivorship at seven years
- None.
Stryker's expansion of its Foot & Ankle portfolio with the Osteotomy Truss System™ (OTS) and Ankle Truss System™ (ATS) is a strategic move to strengthen its position in the orthopedic market. The ATS, featuring Truss Implant Technology™, addresses a critical need in tibiotalocalcaneal (TTC) fusions, potentially improving patient outcomes and surgical efficiency. The OTS's comprehensive range of wedges offers versatility for various osteotomy procedures.
The integration of Artelon's portfolio, particularly the Flexband biomaterial, diversifies Stryker's offerings in soft tissue repair. This expansion, coupled with the continued success of the Infinity Total Ankle System (98.8% survivorship at two years), positions Stryker as a one-stop solution provider in foot and ankle surgery. These innovations could drive market share growth and potentially boost revenue in Stryker's orthopedic segment.
The new Ankle Truss System (ATS) represents a significant advancement in ankle fusion procedures. Its open architecture design, compatible with Stryker's existing nail systems, could potentially reduce surgical complexity and improve fusion rates. The system's availability in three shapes allows for more personalized treatment, which is important in complex ankle pathologies.
The Osteotomy Truss System's comprehensive wedge options provide surgeons with greater flexibility in addressing various foot deformities. This versatility could lead to increased adoption among foot and ankle specialists. The integration of Artelon Flexband adds a valuable tool for soft tissue augmentation, potentially improving outcomes in ligament and tendon repairs. These additions to Stryker's portfolio address key challenges in foot and ankle surgery, potentially improving patient outcomes and surgeon satisfaction.
Stryker's portfolio expansion aligns with the growing demand for advanced orthopedic solutions in the $4.5 billion global foot and ankle devices market. The foot and ankle segment is one of the fastest-growing in orthopedics, with a CAGR of
The company's focus on innovation and comprehensive solutions could help it gain market share from competitors like Wright Medical (now part of Stryker) and Zimmer Biomet. The success of the Infinity Total Ankle System, with its high survivorship rates, provides a strong foundation for cross-selling these new products. However, the effectiveness of Stryker's marketing and education efforts at events like AOFAS will be important in driving adoption among surgeons and maintaining its market position.
The company to feature new products at American Orthopaedic Foot & Ankle Society Annual Meeting
The new Ankle Truss System (ATS), which includes Arthrosphere® and Arthrocube™ implants, is an innovative product designed to restore limb length while providing structural integrity for the limb during tibiotalocalcaneal (TTC) fusions. The ATS implants feature Truss Implant Technology™, offering an open architecture designed to provide structural support and promote fusion. It is cleared for use with Stryker’s T2 Ankle Arthrodesis Nail or Valor Hindfoot Fusion Nail and will be readily available in three different shapes to enable expedited scheduling of surgeries for patients requiring immediate ankle fusion. The Osteotomy Truss System (OTS) is comprised of Cotton, Evans, and Utility wedges, which offers a comprehensive solution for all of a surgeon's osteotomy needs. It is indicated for internal bone fixation and osteotomies in the foot and ankle and is currently available for use. The ATS will debut at the AOFAS annual meeting and will be available in the coming months.
“The addition of the ATS and the integration of Artelon reflects our commitment to providing surgeons with enhanced orthopaedic solutions to achieve the best possible patient outcomes,” said Michael Rankin, vice president of marketing and medical education of Stryker’s Foot & Ankle business. “We will never stop our dedication to advancing our offerings to meet the evolving needs of our customers for all foot and ankle procedures. We look forward to showcasing our expanded portfolio at the AOFAS conference.”
Stryker will also be highlighting several other solutions at AOFAS, booth #601, including for the first time the Artelon Flexband, which is a next-generation biomaterial designed to help restore natural strength and elasticity to healing soft tissues. Stryker will also be celebrating 10 years of excellence of the Infinity Total Ankle System, which is a market leader in low-profile implants, demonstrating
About Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com.
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.
The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.
Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Ankle Truss System, Artelon, Flexband, Infinity, Osteotomy Truss System, Stryker, T2, Valor. All other trademarks are trademarks of their respective owners or holders.
References:
- Townshend D, Bing A, Blundell C, Clough T, Davenport J, Davies H, Davis J, Dhar S, Hepple S, Kakwani R, Karski M, Makwana N, McKinley J, Murty A, Raglan M, Shalaby H, Sharpe I, Smith R, Taylor H, Goldberg A. Two to Five-Year Outcomes of Total Ankle Arthroplasty with the Infinity Fixed-Bearing Implant: A Concise Follow-up of a Previous Report. J Bone Joint Surg Am. 2023 Dec 6;105(23):1846-1856. doi: 10.2106/JBJS.22.01294. Epub 2023 Oct 16. PMID: 38063779; PMCID: PMC10695343.
-
Based on 7-year revision rate from the 20th Annual Report of the
UK National Joint Registry for INFINITY (Table 3.A4)
Copyright © 2024 Stryker
Content ID: AP-017648
View source version on businesswire.com: https://www.businesswire.com/news/home/20240911818131/en/
Media contact
Sampson Public Relations Group
Andrea Sampson
President/CEO
asampson@sampsonprgroup.com
Source: Stryker
FAQ
What new products has Stryker (SYK) added to its Foot & Ankle portfolio?
When and where will Stryker (SYK) showcase its new Foot & Ankle products?
What is the survivorship rate of Stryker's (SYK) Infinity Total Ankle System?
What is the Ankle Truss System (ATS) by Stryker (SYK) designed for?
